Who owns NEUROSENSE THERAPEUTICS LTD?
- Ticker: NRSN
- CUSIP Number: m74240108
Tip: Access positions for across all investors
Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurosense Therapeutics stock
Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Meitav Dash Investments | 50k | $91k | -47% | Mar 2024 |
|
| Woodline Partners | 20k | $36k | 100% | Mar 2024 |
|
| Geode Capital Management | 12k | $22k | 100% | Mar 2024 |
|
| UBS Group | 12k | $22k | 117% | Mar 2024 |
|
| Morgan Stanley | 1.5k | $2.7k | 100% | Mar 2024 |
|
| CWM | 1.0k | $2.0k | 0% | Mar 2024 |
|
| Qube Research & Technologies | 54.00 | $97.999200 | 100% | Mar 2024 |
|
Who sold out of Neurosense Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 662k | $470k |
| Hrt Financial | Dec 2023 | 14k | $10k |